Last updated: April 21, 2026

Application No. 18/814,182

Untitled Application

Unknown

Filed

1600

Examiner

TRAN, ERIC

Art Unit

1629

Tech Center

Diamond Therapeutics Inc.

Assignee

Diamond Therapeutics Inc.

OA Round

2 (Non-Final)

Interview Optional

— +24.0% interview lift. Examiner has a relatively high allowance rate (70%); +24.0% interview lift. A written response may suffice.

Based on 95 resolved cases, 2023–2026

Examiner Intelligence

TRAN, ERIC View full profile →

Grants 70% — above average

Career Allow Rate

66 granted / 95 resolved

+9.5% vs TC avg

Strong +24% interview lift

Without

With

+24.0%

Interview Lift

resolved cases with interview

Typical timeline

2y 8m

Avg Prosecution

35 currently pending

Career history

130

Total Applications

across all art units

Statute-Specific Performance

§101

1.7%

-38.3% vs TC avg

§103

28.9%

-11.1% vs TC avg

§102

16.6%

-23.4% vs TC avg

§112

33.0%

-7.0% vs TC avg

Black line = Tech Center average estimate • Based on career data from 95 resolved cases

Prosecution Timeline

1600

Application Filed

Mar 15, 2025

Non-Final Rejection

Sep 29, 2025

Response Filed

Sep 29, 2025

Response after Non-Final Action

Jan 29, 2026

Non-Final Rejection (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/419,347

Patent 12570629

Process for Preparation of Imidacloprid Polymorph Form I

4y 8m to grant Granted Mar 10, 2026

18/659,374

Patent 12559506

INDAZOLE BASED COMPOUNDS AND ASSOCIATED METHODS OF USE

1y 9m to grant Granted Feb 24, 2026

18/290,244

Patent 12533323

SLOW-RELEASE FORMULATION

2y 2m to grant Granted Jan 27, 2026

18/612,067

Patent 12533367

Self-Emulsifying Systems For Cannabinoids

1y 10m to grant Granted Jan 27, 2026

18/999,662

Patent 12533328

EPINEPHRINE COMPOSITIONS AND CONTAINERS

1y 1m to grant Granted Jan 27, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

2-3

Expected OA Rounds

70%

Grant Probability

94%

With Interview (+24.0%)

2y 8m

Median Time to Grant

Moderate

PTA Risk

Based on 95 resolved cases by this examiner. Grant probability derived from career allow rate.